Eris Biotech

About

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

Founders

• 
  Evita Weagel· Founder/CEO

  PhD in microbiology and molecular biology with an emphasis in cancer immunology, working on developing drugs that reawaken the immune system to fight cancer. First-generation immigrant from Peru. Mom of two boys.

  LinkedIn ↗
• 
  Rachel Garlick· Founder

  PhD in Immunology from Dartmouth College. Engineered many novel cancer immunotherapies. We build cancer drugs that reawaken the immune system to fight cancer for you. No tox, no side effects, and most importantly -- no cancer.

  LinkedIn ↗

Product launches · 1 launch

• Eris Biotech - Developing drugs that reawaken the immune system to kill cancer ↗▲ 186Feb 7, 2024

  Tumors turn OFF the immune system. Our drugs turn the immune system ON to kill cancer.

Change history · 17 recorded

1. October 11, 2026
   • Relocated to Salt Lake City08:00 PM
   • Launches refreshed08:00 PM
   • Founder profile updated08:00 PM
2. September 27, 2026
   • Launches refreshed08:00 PM
   • Founder profile updated08:00 PM
3. September 13, 2026
   • Founder profile updated08:00 PM
   • Launches refreshed08:00 PM
4. August 23, 2026
   • Founder profile updated08:01 PM
   • Launches refreshed08:01 PM
5. August 2, 2026
   • Launches refreshed08:01 PM
   • Founder profile updated08:01 PM
6. July 12, 2026
   • Founder profile updated08:00 PM
   • Launches refreshed08:00 PM
7. June 28, 2026
   • Founder profile updated08:01 PM
   • Launches refreshed08:01 PM
8. June 14, 2026
   • Founder profile updated08:00 PM
   • Launches refreshed08:00 PM